THE EFFICIENCY AND SAFETY OF OBINUTUZUMAB IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY-A RETROSPECTIVE STUDY FROM CHINA

https://storage.unitedwebnetwork.com/files/1099/032136ada9b15baa71c8873294dfab7f.pdf
THE EFFICIENCY AND SAFETY OF OBINUTUZUMAB IN THE TREATMENT OF MEMBRANOUS NEPHROPATHY-A RETROSPECTIVE STUDY FROM CHINA
Chen
Duqun
Tu Yuanmao oldcatec2@163.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
Wang Youliang 1024169623@qq.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
Qiu Dandan 15751866675@163.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
Wang Jingjing jingjingyeyelaile@163.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
Zuo Ke alexzuo_3000@aliyun.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
Cheng Zhen chengzhen33@hotmail.com Jingling Hospital National Clinical Research for Kidney Disease Nanjing, Jiangsu
 
 
 
 
 
 
 
 
 
E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos